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Abstract
The present invention relates to the isolation, puri?cation, sequencing, and functional characterization of the
class I and II terpene sequences OsCPSlem, OsCPS2em, OsCPS4Syn, and OsDTS2. Transcriptional control
of OsCPSlem provides a means of regulating production of gibberellin phytohormone, While transcriptional
control of OsCPS2em, OsDTS2, and OsCPS4Syn provides a means of regulating defensive phy tochemical
biosynthesis. Further, these enzymatic genes offers a means by Which terpenoid production may be more
generally modulated, speci?cally including genetic engineer ing, as Well as ex vivo uses.
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Coding SEQ ID NO: 9 
ATGATTCACCTCCACTCCCCGCCGACGGCGCCCGCCGCATTCGGCGGCGCCGGCTC 
GGCGGACTGGCGGCGGCGGCGGCGGTGGTCATGGTCGTCGTCGTCCCGCGCTCCGGTGGC 
TAAAGGTGGCCATCTTCGTCCGTGCGTTTGGCGGCGCGGCGGCGACGACGGCGGCGGCGA 
GGATCATCACGCCGACAGCGGCGGCGGCGGCGGAGGAGGAGCGGCGTGGAGGGCGCGGGC 
CACCACCGCCGGCGTGTCGAGCTCCAGCAGTACAGCCAAAGGGCTGCAAGCCAACATCAT 
CGAACATGAGACCCCCCGGATCACGAAATGGCCCAATGAATCACGCGACCTCGACGATCA 
CCAACAAAACAACGAGGCTGATGAGGAGGCAGATGATGAGCTGCAGCCACTGGTCGAGCA 
GGTGAGGTCGATGCTGTCGTCCATGGAGGACGGCGCGATCACCGCGTCGGCGTACGACAC 
GGCGTGGGTGGCGCTGGTGCCGCGGCTGGACGGCGAGGGCGGCACGCAGTTCCCGGCCGC 
CGTGCGGTGGATCGTCGGCAGCCAGCTCGCCGACGGGTCGTGGGGCGACGAGGCGCTCTT 
CTCCGCCTACGACCGCGTCATCAACACCCTCGCCTGCGTCGTCGCCCTCACCAGATGGTC 
CCTCCACCATGACCAGTGCAAGCAAGGGCTTCAGTTTCTGAATCTGAACTTGTGGAGGTT 
AGCAGAGGAGGAGCCGGATACGATGCCGATTGGGTTTGAGATTGCATTCCCTTCTCTTGT 
GGAGGCAGCTAGGGGTTTGGGTATTGATTTCCCATATGATCACCCTGCTCTCAAGGGCAT 
TTATGCAAACAGAGAACTCAAGCTTAAGAGGATTCCAAAGGACATGATGCATATAGTCCC 
AACTTCAATTCTGCATAGCCTTGAAGGGATGCCTGGGCTGGATTGGCAGAGGCTTCTGAA 
GCTCCAATGCAGTGATGGATCCTTCTTGTTCTCCCCTTCAGCTACTGCTTATGCTCTCAT 
GCAGACCGGTGACAAGAAATGCTTCGCGTACATCGACAGGATCATTAAGAAATTCGACGG 
TGGCGTTCCGAACGTTTACCCGGTCGATCTTTTTGAGCACATATGGGTTGTCGATCGGTT 
GGAGCGTCTTGGGATATCGCGGTACTTCCAACGAGAGATTGAACAGAACATGGACTATGT 
CAACAGGCACTGGACTGAAGATGGGATTTGCTGGGCTAGGAACTCCAATGTAAAAGAAGT 
GGATGACACCGCTATGGCTTTCCGTCTACTACGCCTCCATGGATACAATGTATCACCAAG 
TGTGTTCAAGAATTTTGAGAAGGATGGGGAGTTCTTCTGTTTTGTGGGGCAATCAACTCA 
AGCAGTCACTGGGATGTATAACCTGAACAGAGCATCTCAGATAAGTTTTCCAGGAGAAGA 
CATTTTGCAGCGTGCAAGGAATTTCTCATATGAGTTCCTTAGAGAAAGAGAAGCCCAGGG 
GACACTTCATGATAAATGGATCATCTCCAAGGACCTACCAGGAGAGGTACAATACACACT 
AGATTTTCCTTGGTATGCGAGCTTGCCACGCGTCGAGGCAAGAACATACATAGGTCAATA 
TGGTGGAAATGATGACGTCTGGATTGGAAAGACACTCTACAGGATGCCAATTGTGAATAA 
CGCTACATATCTCGAGTTGGCGAAACAGGATTTCAACCGTTGTCAAGCTCTACATCAGCA 
TGAGTTGCAGGGTCTACAAAAGTGGTTCATTGAGAATGGCCTGGAAGCTTTTGGGATGAC 
ACCTGAAGATGTTTTGAGAGCTTATTTTTTGGCTGCCGCGTGCATTTTCGAACCAAACCG 
TGCCTCTGAGCGACTTGCATGGGCTAGAGTGTCAGTGCTGGCCAACACTATTTCTAGGCA 
TTTTTACAGCGATATGTCAAGCATGAAAAGGATGGAGCGTTTCATGTGGAGCAGCCTCTA 
TGAAGAAAATGGCAATGTTTTGGGGCTAGAAGGATATGCAAAAGATGGAATCCTTGCGAG 
GACACTTTGTCAACTTATAGATTTGTTGTCTCAAGAGACACCGCCAGTTCGAGAAGGTCA 
AAAGTGTATTCATAATCTCATAAGATGTGCTTGGATTGAATGGATGATGCAACAAATCAA 
TATGAAGGATGGCAGATATGACAAAGGCAGAGTTATGCATCCAGGGTCATGCACTGTTCA 
TAATAAAGAAACATGTTTACTTATTGCTCAAATTGTTGAAATTTGTGCTGGACGAATTGA 
GGAGGCAGCATCTATGATAAATAACACCGAAGGTTCTTGGTTTATTCAACTTGCTTCCTC 
TATTTGCGATTCTCTTCATGCCAAGATGTTACTTTCACAGGATACCAAGAAAAATGAGAC 
AACAATAAATCAAATTGACAAGGAAATTGAGTTGGGTATGCAAGAACTTGCTCAATATCT 
TCTTCCAAGAGTTGATGATAGAAGAATTAACAACAAAACCAAGCAGACCTTCTTGAGCAT 
TGTGAAAAGCTGTTACTATGCTGCCAATTGCTCACCACATATGCTTGACCAACACATTTC 
TGAAGTGATTTTTGAGCAAGTTATTTGA 
Fig. 9B 
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>OsCPSsyn (our indica 0328 sequence; AY530101) SEQ ID NO:4 
MPVFTASFQC 
KSPPYPASEE 
ISAYDTSLVA 
RIMSTLACVV 
ALPSLLDMAK 
HSLEGMVDLD 
VKKFNGGVPC 
TPDGLAHTKN 
HGESNPSSVT 
KDKWAIAKDI 
HRMTLFCNDL 
QTTLMTSYFL 
TSNLEELISL 
VRAIEIFGGR 
EKVEEIDQQL 
PETIDNHIDK 
5' UTR SEQ 
cgactggagcacgtaggacactgacatggactgaaggagtagtaaaatcattcatccca 
atatctattgcatctgcaagagcgatcgagagagaaaaacaagatctatctatagcagc 
VTLFGQPASA 
TREWEAEGQH 
LLKRLDGGDG 
ALKSWNIHTD 
DLDLDIPYDE 
WEKLLKLRCL 
IYPLDVYERL 
CPVKDIDDTA 
PMYNTYRASQ 
PGEVEYAMDY 
YLKAAKADFS 
ASANIFEPNR 
VPFDDAYSGS 
HVLTGQRPDL 
DLEMQELTRR 
VIFQDVI 
ID NOzlB 
ADAQPLLQGQ 
EHTDELRETT 
PQFPSTIDWI 
KCERGLLFIQ 
PALKAIYAER 
DGSFHCSPAS 
WAVDRLTRLG 
MGFRLLRLYG 
LKFPGDDGVL 
PWKASLPRIE 
NFQKECRVEL 
AAERLGWARV 
LREAWKQWLM 
WEYSQLEQLT 
VLQGCSAINR 
RPFLHLHARR 
TTMIDGIRTA 
VQNQLPDGSW 
ENMWRLAHEE 
ERKLAKIPRD 
TATAFQQTGD 
ISRHFTSEIE 
YQVDPCVLKK 
GRAEVFCRSF 
TRLYLDQYGG 
NGLRRWYLRS 
ALLADAVSSH 
AWTAKESSQE 
SSICRKLYRR 
LTRETFLHVV 
Fig. 1 7A 
tagctagctagcacaagaacgat 
Fig. 1 7B 
RRPCGPMLIS 
LRSIGEGEIS 
GDASFFMMGD 
EDWMLVGFEI 
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LQDRRGSNRM 
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US. Patent 
>OSDTS2 
MASPMEAVAR 
SFACSAELDT 
IRRHLENPEF 
GSWGVNEFDS 
VIDDQIAAPI 
LSGEESLGKE 
LVHRYDDKAL 
FSSDIKRILD 
HVAEASTFHN 
LKEKLCSDDI 
IKTKNMPCHV 
TRKNLINSYL 
QENLISLVEK 
TKYNVESWLD 
LYFMGQNLWE 
SLLVLDSKDV 
WNLYKTSHVF 
Apr. 28, 2009 
SSLVLAPRRR 
GRRQLPSTGT 
LPSSYDIAWV 
SASKDILLST 
GFNLTFPAMV 
AYFAYIAEGL 
GYLYSVVNKF 
KTYILWSQRD 
SVEGYLDDTK 
RGTPILGEVE 
NEDLLALAAE 
SAAATISPYE 
WDQYHKVEF’Y 
YLRSLATDAE 
DIVKNAEYDE 
MSVEEAKEAI 
YSQADGFSSP 
RALGLLPAAA 
RAVMSSCPGY 
AMVPLPGTDH 
LACIIALEKW 
NLAIKMGLEF 
EESMVDWSEV 
GGEVPTVYPL 
EEVMLDLPTC 
SLLELYKASK 
YALKFPFYAT 
DFSFCQSTYQ 
LSDARIACAK 
SENVKAVFFA 
WQRSKYVPTM 
LFRLMNTCGR 
NESISSCRRE 
KEMMGAMNGV 
Sheet 14 0f 15 
(our indica @321 sequence; AY616862) 
APFVLDCRRR 
VEGRMVGENT 
LQAPCFPECV 
NVGSEQIRRG 
PASEISIDQI 
MKFQGKNGSL 
NIFSQLSMVD 
AMAFRLLRMN 
VSLSENEPIL 
LEPLDHKWNI 
NEIQHLESWE 
SIALTLVADD 
LYSTVNQLGA 
EEYMKNSIVT 
LQNDIQSFER 
LLRLVVREDG 
IFEPLKTRGN 
M94214 
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SEQ ID NO: 8 
HNGGMRRPHV 
SQINMGREAR 
EWILQNQHSN 
LHFIAKNFSI 
LHLRDMELKR 
FNSPAATAAA 
TLVNIGISRH 
GYGVSSDDLS 
EKMGCWSGSL 
ENFDARAYQK 
KENKLDQLEF 
FFDVGSSKEE 
MASAVQNRDV 
FALGPTILIA 
ECKDGKLNSV 
VIPKSCKEMF 
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Coding SEQ ID NO:16 
atggcgagtcctatggaagctgtagcccgttccagcctcgtgctcgcacctcgccggcg 
gcgagccctcggcctcctcccggcggcggccgccccattcgtgctagattgtcgccggc 
ggcataacggaggaatgcgtcgtcctcatgtcagcttcgcctgctcggccgagctcgac 
accggtcgccggcagcttccttccacggggactcgagcggtgatgtcgtcctgtcccgg 
atatgttgaggggaggatggtaggagaaaatacaagtcagataaacatgggacgggagg 
ctagaatacgtaggcacttggagaacccggagttcttaccatcttcatatgacatagca 
tgggtggctatggtgccattgccgggcactgatcatcttcaagctccatgcttccctga 
atgtgtggaatggatactacaaaaccaacacagtaatgggtcgtggggtgtcaatgaat 
ttgactcatcagccagcaaggatattctcctatccactttggcatgtattattgcactt 
gagaaatggaatgtcggttcggagcaaataaggagaggattacattttatcgcaaagaa 
tttctccattgttattgatgaccagattgctgcacctataggcttcaacctcacattcc 
ctgctatggttaaccttgccattaagatgggtttggaatttcctgccagtgaaattagt 
attgatcagattcttcacctccgtgatatggaattgaaaagactgtctggtgaggaatc 
tttggggaaagaggcatatttcgcctatattgctgaaggtctagaagaaagcatggtgg 
attggagtgaagttatgaagttccaggggaagaatggatcattgttcaactccccggct 
gcaactgctgctgcattagtccacagatacgatgataaagccctgggatacctatattc 
tgttgtcaataaatttqqaggtgaaqtaccaaccgtgtatccgctaaatatattttctc 
agctttcaatggtggatactctcgtcaatattggaatatctcggcacttttctagtgat 
ataaagcgcattttggataagacatacattttatggtcacagagagatgaggaagtaat 
gctggatttaccaacatgcgcaatggcatttcgccttttgcgtatgaacggatatggtg 
tttcctcagatgacttgtcccatgttgctgaagcctcaactttccataactcagttgaa 
ggatacttagatgatacaaaatccttattagaattgtacaaagcttcaaaagtcagttt 
atcagaaaatgagccaatcctagagaaaatgggttgctggtcaggtagcttattgaaag 
aaaaattgtgctccgatgacatccgaggaacaccaatccttggagaggtagaatatgct 
ctcaaatttccattttatgccacgctggaacctctagaccacaagtggaacattgaaaa 
ttttgatgccagggcttatcagaagataaagaccaaaaacatgccgtgccatgtcaatg 
aagatctcttggctttggctgctgaagatttcagcttttgtcagtcaacttaccaaaat 
gaaatccagcaccttgaaagttgggagaaagaaaataagctggaccagctcgaatttac 
gcggaagaatctaataaacagctatctctctgctgctgccaccataagcccttatgaat 
tgtctgatgctcgcattgcgtgtgcaaaatctattgcgctcacacttgttgccgatgac 
ttttttgatgtcggaagttccaaagaagaacaagaaaatctcatatccttagtcgagaa 
gtgggatcagtatcataaagttgagttctactctgagaatgtaaaagcagtatttttcg 
ctctatattctacggttaaccagcttggagcaatggcttccgcagtacagaaccgcgac 
gttacaaaatacaatgttgaatcgtggttggattatttgaggtctttagcgacagatgc 
aqaatqqcaacqqaqcaaatatqtqccaacaatqqaqqaatacatqaaaaattcaattq 
tgacattcgcattgggaccaactatactcatagcactgtatttcatgggacaaaatctc 
tgggaggacatcgtgaaaaatgcagagtatgatgagttgtttagactaatgaacacatg 
tggtcgtctccagaatgatattcaaagctttgagagggaatgcaaggatggcaaactga 
acagtgtgtcactgcttgttcttgacagcaaagatgtcatgtcagtagaagagqctaaa 
gaggcgataaacgagtctatatcatcatgtagaagagagttgctacggttggttgttag 
agaagacggtgtcattcctaaatcatgcaaggagatgttctggaatctttacaagacaa 
gccatgtgttctactctcaggccgatggattttcctcgccgaaggaaatgatgggtgct 
atqaatggagtaatctttgagccactqaaaactagaggcaactag 
Fig. 725 
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IDENTIFICATION OF SYN-COPALYL 
DIPHOSPHATE SYNTHASE 
CROSS-REFERENCE TO RELATED 
APPLICATION 
The present invention claims priority to US. Provisional 
Application Ser. No. 60/573,472, ?led May 21, 2004 the 
disclosure of Which is expressly incorporated by reference. 
GRANT REFERENCE CLAUSE 
This invention Was funded at least in part by USDA/CS 
REES 2005 -353 1 8-1 5477. The government may oWn certain 
rights in this invention. 
BACKGROUND OF THE INVENTION 
Plants produce a vast and diverse array of loW-molecular 
Weight organic compounds. A small number of these are 
primary metabolites, Which are common to all plant species 
as they are directly required for growth and development. The 
remaining, overWhelming majority of these natural products 
are considered secondary metabolites and are not found in all 
plants. Thus, individual species produce a limited subset of all 
plant natural products, although families Will sometimes 
share common secondary metabolism (e.g., oleoresinosis in 
Pinaceae). Nevertheless, many secondary metabolites have 
important ecological roles, particularly in plant defense. 
(Croteau et al. 2000). For example, phytoalexins are produced 
in response to microbial infections and exhibit antimicrobial 
properties (VanEtten et al. 1994), While allelochemicals are 
secreted to the rhiZosphere, and suppress germination and 
groWth of neighboring seeds (Bais et al. 2004). 
Particularly abundant in plants, as both primary and sec 
ondary metabolites, are terpenoids, Which comprise the larg 
est class of natural products and exhibit Wide diversity in 
chemical structure and biological function (Croteau et al. 
2000). Much of the structural variation Within this class arises 
from the diverse carbon backbones formed by terpene syn 
thases (cyclases). These divalent metal ion dependent 
enZymes carry out complex electrophilic cycliZations and/or 
rearrangements to create these diverse skeletal structures 
from relatively simple acyclic precursors (Davis and Croteau 
2000). Notably, production of a speci?c backbone structure 
either dictates, or at least severely restricts, the metabolic fate 
of that particular molecule. Thus, terpenoid biosynthesis is 
often controlled, at least in part, by regulating terpene syn 
thase activity [eg giberellin biosynthesis; (Silverstone et al. 
1 997)] . 
A substantial fraction of the knoWn terpenoids can be clas 
si?ed as labdane-related diterpenoids (20 carbon). These are 
de?ned here as minimally containing the bicyclic hydrocar 
bon structure found in the labdane class of diterpenoids, 
although this core structure can be further cycliZed and rear 
ranged, as in the related/ derived structural classes (e. g., kau 
ranes, abietanes, and [iso]pimaranes). Signi?cantly, this 
includes the primary metabolite gibberellin groWth hor 
mones. HoWever, the vast majority of the more than 5,000 
knoWn labdane-related diterpenoids are secondary metabo 
lites. 
Biosynthesis of labdane-related diterpenoids is initiated by 
class II terpene synthases Which catalyZe formation of the 
characteristic bicyclic backbone in producing speci?c stere 
oisomers of labdadienyl/copalyl disphosphate (CPP) from 
the universal diterpenoid precursor, and plant primary 
metabolite, (E,E,E)-geranylgeranyl diphosphonate (GGPP). 
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In addition, this core bicyclic structure is alWays further 
modi?ed by stereoselective CPP speci?c class I terpene syn 
thases (i.e. ioniZation of the diphosphate moiety to form one 
or more neW carbon-carbon bonds). Thus, class II and class I 
terpene synthases act sequentially in catalyZing stereochemi 
cally coupled cycliZation reactions to form labdane-related 
diterpene skeletal backbones. 
Signi?cantly, the class II protonation-initiated bicycliZa 
tion reaction is fundamentally different than the dipho sphate 
ioniZation initiated reactions catalyZed by the more common 
class I terpene synthases. Nevertheless, the class II cyclases 
clearly fall Within the terpene synthase gene family (Bohl 
mann et al. 1998b). HoWever, rather than the DDXXD metal 
binding motif functionally associated With class I activity 
(Davis and Croteau 2000), class II terpene cyclases contain a 
distinct DXDD motif (Sun and Kamiya 1994) Which has been 
functionally associated With class II cycliZation reactions 
(Peters et al. 2001). 
Prototypical plant class I terpene synthases are similar in 
siZe and contain tWo structurally de?ned domains (Starks et 
al. 1997; Whittington et al. 2002). HoWever, some terpene 
synthases, and in particular all of those involved in labdane 
related diterpenoid biosynthesis, contain a large amount of 
additional amino terminal sequence termed the ‘insertional’ 
element [approximately 240 amino acid residues; (Peters and 
Croteau 2002)]. Notably, given adequate sequence informa 
tion, this speci?c structural feature is useful for putative iden 
ti?cation of labdane-related diterpene synthases, although it 
is not suf?cient for even such generaliZed functional annota 
tion [e.g. (Bohlmann et al. 1998a)]. 
Rice (Oryza saliva) provides a model system to investigate 
labdane-related diterpenoid biosynthesis, as this Well charac 
teriZed plant is knoWn to produce a number of such natural 
products beyond the ubiquitous gibberellic acid (GA) groWth 
hormones (FIG. 1). These compounds include momilactones 
A and B (Kato et al. 1973; CartWright et al. 1981), oryZalexins 
A to F (Akatsuka et al. 1985; Sekido et al. 1986; Kato et al. 
1993; 1994), oryZalexin S (Kodama et al. 1992), and phyto 
cassanes A to E (Koga et al. 1995; Koga et al. 1997). All of 
these natural products are produced in leaves in response to 
infection With the blast pathogenic fungus Magneporlha 
grisea and exhibit antimicrobial properties; thus qualifying as 
phytoalexins (VanEtten et al. 1994). In addition, momilac 
tones A and B also act as allelochemicals, as these Were 
originally identi?ed as dormancy factors from rice seed husks 
(Kato et al. 1973), and momilactone B has recently been 
shoWn to be constitutively secreted from the roots of rice 
seedlings, Where it acts as an allelopathic agent (Kato-Nogu 
chi and Ino 2003). Further, secretion of antimicrobial agents 
to the rhiZosphere may also provide a competitive advantage 
for root establishment through local suppression of soil 
micro-organisms (Bais et al. 2004). 
Conveniently, rice leaves produce all of these secondary 
metabolites after UV irradiation as Well as blast fungal infec 
tion (Kodama et al. 1988), providing a standard method for 
inducing bio synthesis of these natural products and, presum 
ably, transcription of the corresponding enZymatic machin 
ery. In particular, it has previously been shoWn that UV irra 
diation induces biosynthesis of ent-sandaracopimaradiene, 
syn-pimara-7,15-diene, and syn-stemar-13-ene, the putative 
precursors to oryZalexins A to F, momilactones A and B, and 
oryZalexin S, respectively (Wickham and West 1992). These 
polycyclic diterpene hydrocarbons further have been demon 
strated to be selectively produced via CPP of the correspond 
ing stereochemistry [i.e. ent or syn; (Mohan et al. 1996)]. 
More recent Work has identi?ed the class I diterpene synthase 
producing ent-cassa-12,15-diene, the putative precursor to 
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phytocassanes A to E (Yajima et al. 2004), stereoselectively 
from ent-CPP (Cho et al. 2004). In addition, it Was also 
recently reported that only a single CPP synthase gene (Os 
CPS1) is involved in GA biosynthesis, although no sequence 
information Was presented (Sakamoto et al. 2004). Thus, 
gene function Was demonstrated by the severe groWth defect 
(i.e. dWarf phenotype) of the corresponding mutant (i.e. 
T-DNA insertion) plant, along With its rescue by exogenous 
application of GA3. Finally, although other putative class II 
and class I labdane-related diterpene synthase genes can be 
found in the rice genome, gene isolation and biochemical 
characterization have not been previously reported, leaving in 
question the role and speci?c activity of these additional 
cyclases. 
It is therefore a primary objective of the present invention 
to identify, isolate and purify nucleic acid fragments encoding 
class II terpene synthases. 
It is a further objective of the present invention to identify, 
isolate, and purify a nucleic acid fragment encoding a syn 
copalyl diphosphate synthase. 
It is still a further objective of the present invention to 
identify, isolate, and purify a nucleic acid fragment encoding 
a syn-copalyl diphosphate speci?c 9[3-pimara-7,15-diene 
synthase. 
It is a further objective of the present invention to identify, 
isolate, and purify a nucleic acid fragment encoding ent 
copalyl diphosphate synthases. 
It is a further objective of the present invention to provide 
a method of modulating terpenoid biosynthesis. 
It is a further objective of the present invention to provide 
a method of modulating expression of class II terpene syn 
thases. 
It is yet a further objective of the present invention to 
provide a method of modulating expression of a syn-copalyl 
disphosphate. 
It is a further objective of the present invention to provide 
a method of modulating expression of syn-copalyl diphos 
phate speci?c pimara-7,15-diene synthase. 
It is a further objective of the present invention to provide 
a method of modulating expression of ent-copalyl diphos 
phate synthases. 
The method and means of accomplishing each of the above 
objectives as Well as others Will become apparent from the 
detailed description of the invention Which folloWs hereafter. 
SUMMARY OF THE INVENTION 
The present invention relates to the functional identi?ca 
tion of three class II labdane-related diterpene cyclases; a 
syn-CPP synthase, namely OsCPS4Syn, along With tWo dis 
parate ent-CPP synthases, namely OsCPSlem and 
OsCPS2em. OsCPS4Syn is involved in the production of defen 
sive natural products (i.e. phytoalexins/allelochemicals; FIG. 
1). Accordingly, OsCPS4Syn mRNA is speci?cally induced in 
leaves prior to production of the corresponding phytoalexins. 
Thus, transcriptional control of OsCPS4Syn appears to be an 
important means of controlling biosynthesis of syn-copalyl 
diphosphate derived phytochemicals. OsCPSlem has been 
found to normally operate in GA biosynthesis as mutations in 
this gene result in severely impaired groWth. Further, 
OsCPS2em is involved in related secondary metabolism pro 
ducing defensive natural products. In particular, OsCPS2em 
mRNA is speci?cally induced in leaves prior to the produc 
tion of the corresponding phytoalexins. Thus, transcriptional 
control of OsCPS2em also appears to be an important means 
of regulating the production of the corresponding ent-copalyl 
diphosphate derived defensive phytochemicals. 
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The invention further relates to the identi?cation of the 
syn-CPP speci?c class I labdane-related 9[3-pimara-7,15-di 
ene diterpene synthase, namely OsDTS2. OsDTS2 is 
involved in the production of the phytoalexins/allelochemi 
cals momilactones A and B. Accordingly, OsDTS2 mRNA is 
also speci?c induced in leaves prior to the production of the 
corresponding natural products. Thus, transcriptional control 
of OsDTS2 appears to be an important means of speci?cally 
controlling biosynthesis of the momilactones and any other 
9[3-pimara-7,15-diene derived natural products. 
In accordance With this invention, OsCPSlem, OsCPS2em, 
OsCPS4Syn, and OsDTS2 have been identi?ed, sequenced, 
isolated, and biochemically characterized. The isolation and 
functional identi?cation of these labdane-related diterpene 
synthases provides a means of modifying enzymes and meta 
bolic pathWays for the production of targeted libraries and 
speci?c individual terpenoid products. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shoWs the knoWn cyclization steps in rice labdane 
related diterpenoid biosynthesis. Reactions catalyzed by 
class II (tpsII) or class I (tpsI) terpene synthases are indicated, 
along With the families of natural products derived from each 
of the named polycyclic hydrocarbon structures (dashed 
arroWs indicate multiple enzymatic steps). 
FIG. 2 shoWs the amino acid alignment of class II terpene 
synthases from the cereal/ grass family of plants (Poaceae): 
ZmCPSlem (SEQ ID N011), OsCPSlem (SEQ ID NO:2), 
OsCPS2em (SEQ ID N013), and OsCPS4Syn (SEQ ID NO:4). 
Truncations for recombinant pseudomature constructs are 
indicated by the arrowhead and the (D,E)XD(D,N) motif by 
an underline. 
FIG. 3 shoWs identi?cation of enzymatic products for 
OsCPS4Syn: A) GC-MS analysis (275 m/z extracted ion chro 
matographs) of the dephosphorylated reaction product from 
GGPP, B) Mass spectrum of the enzymatic GC-MS 275 m/z 
chromatograph peak (RT:13.45 min.), C) Mass spectrum of 
authentic dephosphorylated syn-CPP (i.e. syn-copalol), 
Which also exhibits RT:13.45 min. 
FIG. 4 shoWs identi?cation of enzymatic products for 
OsCPSlem and OsCPS2em: A) GC-MS analysis (275 m/z 
extracted ion chromato graphs) of the depho sphorylated reac 
tion products from GGPP produced by the indicated enzyme, 
B) Mass spectrum of the GC-MS 275 m/z chromatograph 
peak for OsCPS1em(RT:14.12 min.); C) that for OsCPS2em 
(RT:14.12 min.); D) that for authentic dephosphorylated ent 
CPP (i.e. ent-copalol), Which also exhibits RT:14.12 min. 
FIG. 5 shoWs identi?cation of enzymatic products for 
OsDTS2: A) GC-MS analysis (272 m/z extracted ion chro 
matographs) of the reaction product from syn-CPP, B) Mass 
spectrum of the enzymatic GC-MS 272 m/z chromatograph 
peak (RT:12.74 min.), C) Mass spectrum of authentic 96-pi 
mara-7,15-diene, Which also exhibits RT:12.74 min. 
FIG. 6 shoWs expression analysis of OsCPS4Syn; A) 
Graphical comparison of OsCPSSyn mRNA levels (closed 
circles) and phytoalexin accumulation [open circles; as 
described by (Kodama et al., 1988)], in UV-irradiated 
detached leaves. Quantitative RT-PCR analysis of OsCPSSyn 
mRNA expression levels is shoWn in B) and C). Speci?c 
bands corresponding to the 18S rRNA internal control and 
OsCPSSyn are indicated. B) Expression in response to UV 
irradiation. Time (hours) after exposure is indicated 
(c:control leaves after ~18 hours). C) Expression in untreated 
four Week old plant roots (R), or in germinated seedlings in 
response to application of 0.5 mM methyl jasmonate 
(+MeJA) or Water control (-MeJA); II) OsCPSlem and 
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0sCPS2em1 Semi-quantitative RT-PCR analysis of mRNA 
expression levels for the indicated genes. Speci?c bands cor 
responding to CPS or the 18S rRNA control are indicated. 
FIG. 7 shoWs expression analysis of 0sCPS2em; A) 
Expression in germinated seedlings in response to application 
of 0.5 mM MeJA, B) Expression of 0sCPS2em in detached 
leaves from 4-Week-old plants in response to UV irradiation. 
Time (hours) after exposure is indicated (c:control leaves 
after approximately 18 h), C) Relative graphical comparison 
of 0sCPS2em mRNA levels (black circles) and ent-labdane 
related diterpenoidphytoalexins accumulation (White circles; 
as described by Kodama et al., 1988) in UV-irradiated 
detached leaves. 
FIG. 8 shoWs expression analysis of 0sDTS21 A) Graphi 
cal comparison of 0sDTS2 mRNA levels (closed circles) and 
momilactone accumulation [open circles; as described by 
(Kodama et al., 1988)], in UV-irradiated detached leaves. 
Semi-quantitative RT-PCR analysis of 0sDTS2 mRNA 
expression levels is shoWn in B) and C). Speci?c bands cor 
responding to the 18S rRNA control and 0sDTS2 (DTS) are 
indicated. B) Expression in response to UV-irradiation. Time 
(hours) after exposure is indicated (c:control leaves after ~18 
hours). C) Expression in untreated four-Week old plant roots 
(R), or in germinated seedlings in response to application of 
0.5 mM methyl jasmonate (+MeJA) or Water control 
(-MeJA). 
FIGS. 9A-9B illustrate the amino acid (SEQ ID N012) and 
nucleotide sequence (SEQ ID N019) listings for 0sCPS1em. 
FIGS. 10A-10D illustrate the amino acid (SEQ ID N013) 
and nucleotide sequence (SEQ ID NOS110-12) listings for 
0sCPS2em. 
FIGS. 11A-11D illustrate the amino acid (SEQ ID N014) 
and nucleotide sequence (SEQ ID N0113-15) listings for 
0sCPS4Syn. 
FIGS. 12A-12B illustrate the amino acid (SEQ ID N018) 
and nucleotide sequence (SEQ ID N0116) listings for 
0sDTS2. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention describes the labdane-related diter 
pene synthases 0sCPS1em, 0sCPS2em, 0sCPS4Syn, and 
0sDTS2. The inventors have determined that While 
0sCPS1 is responsible for GA biosynthesis, 0sCPS2em, 
0sCPS4Syn, and 0sDTS2 act in defensive secondary metabo 
lism. Further, as expected for a role in initiating labdane 
related diterpenoid biosynthesis, transcription of 0sCPS2em, 
0sCPS4Syn, and 0sDTS2 is induced by conditions that stimu 
late phytoalexins biosynthesis, indicating regulatory control 
points for these important metabolic processes. 
Due to the inventors’ interest in labdane-related diterpene 
synthases as potentially signi?cant targets for metabolic engi 
neering and biochemical analysis, they searched the extensive 
sequence information available for rice (Goff et al. 2002; Yu 
et al. 2002; Kikuchi et al. 2003) and identi?ed three putative 
class II diterpene cyclases and one putative labdane-related 
class I diterpene synthase. One of the class II enZymatic genes 
Was readily ampli?ed from mRNA prepared from UV-irradi 
ated rice leaves, and its sequence deposited into the various 
nucleotide databases as accession AY530101. The second 
class II synthase gene Was not as easily isolated. Neverthe 
less, the inventors Were able to successfully clone the corre 
sponding full-length cDNA and have deposited the associated 
sequence into the various nucleotide databases as accession 
AY602991. The third class II gene Was available from the rice 
full-length cDNA sequencing project (accession AK100333; 
Kikuchi et al., 2003) and obtained from the Rice Genome 
ent 
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Resource Center (WWW.rgrc.dna.affrc.go.jp). Notably, this 
last gene sequence contains EXDD in place of the otherWise 
conserved DXDD motif functionally associated With class II 
cycliZation. This Was con?rmed by independently cloning a 
gene fragment covering this region. Finally, the putative class 
I labdane-related terpene synthase Was also cloned from UV 
irradiated leaves and the associated sequence deposited into 
the various nucleotide databases as accession AY616862. 
For each of the class II genes, truncated versions Were 
constructed for recombinant expression. (See FIG. 2, SEQ ID 
NOS11-4). These Were based on truncation analysis of the 
Arabidopsis CPSem. EnZymatic assays Were carried out With 
partially puri?ed recombinant preparations and GGPP as sub 
strate. Phosphatase treatment Was then employed to remove 
the pyrophosphate from GGPP and any enZymatically 
formed derivative to enable straightforWard extraction of the 
resulting alcohol into organic solvent. EnZymatic conversion 
of GGPP Was analyZed by gas chromatography-mass spec 
trometry (GC-MS) of the resulting extracts, demonstrating 
production of an altered prenyl diphosphate structure. Com 
parison of the enZymatically formed compounds to similarly 
dephosphorylated authentic samples of ent- and syn-CPP 
(FIGS. 3-5) demonstrated that the ?rst class II enZyme (acces 
sion AY530101) produces syn-CPP (and so Was named 
0sCPS4Syn), While the other tWo class II cyclases (accessions 
AK100333 and AY602991) both proved to produce ent-CPP 
(and so Were named 0sCPS1em and 0sCPS2em, respec 
tively). The isolated class I gene Was expressed as a glu 
tathione-S-transferase (GST) fusion protein, puri?ed, and 
assayed With GGPP, ent-CPP, or syn-CPP as substrate, fol 
loWed by organic extraction and GC-MS analysis. EnZymatic 
conversion Was only observed With syn-CPP, as no products 
Were detected from incubations With GGPP or ent-CPP. 
Therefore, this is a labdane-related diterpene synthase and 
Was named 0sDTS2. Further, 0sDTS2 is stereoselective and 
represents the ?rst identi?ed class I terpene synthase speci?c 
for syn-CPP. In addition, comparison With the knoWn syn 
thetic standards (Mohan et al. 1996) identi?ed the 0sDTS2 
enZymatic product as 9[3-pimara-7,15-diene. 
The recent publication by Sakamoto et al. (2004) clearly 
demonstrated that only a single class II terpene cyclase, 
Which they termed 0sCPS1, is normally involved in GA 
metabolism. One of the tWo ent-CPP synthases identi?ed 
herein corresponds to 0sCPS1, speci?cally, the gene derived 
from the large-scale cDNA project (accession AK100033) 
that has been designated 0sCPS1em to more precisely re?ect 
its function. Because the other functional ent-CPP synthase 
identi?ed here (accession AY602991) does not compensate 
for mutations in 0sCPS1em and, therefore, is not expressed in 
conjunction With GA biosynthesis, the inventors hypoth 
esiZed that this gene (designated 0sCPS2em as it corresponds 
to the 0sCPS2 of Sakamoto et al., 2004) might be altema 
tively expressed for production of the knoWn ent-labdane 
related diterpenoid defensive secondary metabolites. Further, 
the syn-CPP synthase (Which Was designated 0sCPS4Syn as it 
corresponds to the 0sCPS4 of Sakamoto et al., 2004), as Well 
as the subsequently acting 0sDTS2, must be involved in 
biosynthesis of defensive secondary metabolites as this is the 
function of all syn-labdane-related diterpenoids in rice (FIG. 
1). The involvement of 0sCPS2em, 0sCPS4Syn, and 0sDTS2 
in defensive secondary metabolism Was initially examined by 
characterization of gene transcription in response to methyl 
jamsonate (MeJA). Application of this important plant 
defense signaling molecule previously has been shoWn to 
induce phytoalexin biosynthesis in rice cell culture (Nojiri et 
al. 1996). While transcription of the GA-speci?c 0sCPS1 
gene is not signi?cantly altered, 0sCPS2 0sCPS4 
ent 
and 
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OsDTS2 mRNA levels Were consistently increased by MeJA 
treatment (FIGS. 6-8), thus indicating a role for these 
enzymes in defensive secondary metabolism. 
Previous revieW of the relevant literature has been used to 
suggest that plant secondary metabolism is most often regu 
lated at the level of transcription (Peters and Croteau 2004). 
Transcriptional control is manifested by up-regulation of 
enZymatic mRNA levels, With subsequent phytochemical 
accumulation, in response to the appropriate environmental 
conditions. This Was investigated through use of UV irradia 
tion, Which has long been appreciated to induce phytoalexin 
biosynthesis in rice (Cartwright et al. 1977). In addition, 
quantitative analysis of phytochemical accumulation for the 
detached leaf UV-irradiation method used here has previ 
ously been reported (Kodama et al. 1988). Consistent With the 
indicated role in phytoalexin biosynthesis, transcription of 
OsCPS2em, OsCPS4Syn and OsDTS2 is dramatically 
increased by UV-irradiation prior to accumulation of the 
derived natural products (FIGS. 6-8). These results not only 
demonstrate that these enZymes are involved in defensive 
secondary metabolism, but further indicate that bio synthesis 
of the labdane-related diterpenoid phytoalexins also may be 
regulated, at least to some extent, through transcriptional 
control of the associated terpene synthases. 
As used here, the term “isolated” means any class I or II 
terpene synthase of the present invention, or any gene encod 
ing a class I or II terpene synthase, Which is essentially free of 
other polypeptides or genes, respectively, or of other contami 
nants With Which the class I or II terpene synthase polypeptide 
or gene might normally be found in nature. 
The invention includes a functional polypeptide, 
OsCPSl OsCPS2 OsCPS or OsDTS2 and func 
tional fragments thereof. As used herein, the term “functional 
polypeptide” refers to a polypeptide Which possesses a bio 
logical function or activity Which is identi?ed through a 
de?ned functional assay and Which is associated With a par 
ticular biologic, morphologic, or phenotypic alteration in the 
cell. The biological function, for example, can vary from a 
polypeptide fragment as small as an epitope to Which an 
antibody molecule can bind to a large polypeptide Which is 
capable of participating in the characteristic induction or 
programming of phenotypic changes Within a cell. A “func 
tional polynucleotide” denotes a polynucleotide Which 
encodes a functional polypeptide as described herein. 
Minor modi?cations of the primary amino acid sequences 
of the terpene synthases of this invention may result in pro 
teins Which have substantially equivalent activity as com 
pared to the polypeptides described herein. Such modi?ca 
tions may be deliberate, as by site-directed mutagenesis, or 
may be spontaneous. All of the polypeptides produced by 
these modi?cations are included herein as long as the 
described activities of the terpene synthases are present. Fur 
ther, deletion of one or more amino acids can also result in a 
modi?cation of the structure of the resultant molecule With 
out signi?cantly altering its biological activity. This can lead 
to the development of a smaller active molecule Which Would 
have broader utility. For example, it is possible to remove 
amino or carboxy terminal amino acids Which may not be 
required for biological activity. 
The polypeptides of the invention also include conserva 
tive variations of the polypeptide sequences. The term “con 
servative variation” as used herein denotes the replacement of 
an amino acid residue by another, biologically similar resi 
due. Examples of conservative variations include the substi 
tution of one hydrophobic residue such as isoleucine, valine, 
leucine or methionine for another, or the substitution of one 
polar residue for another, such as the substitution of arginine 
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for lysine, glutamic for aspartic acids, or glutamine for aspar 
agine, and the like. The term “conservative variation” also 
includes the use of a substituted amino acid in place of an 
unsubstituted parent amino acid provided that antibodies 
raised to the substituted polypeptide also immunoreact With 
the unsubstituted polypeptide. 
The invention is also intended to include synthetic pep 
tides. The amino acid sequences of SEQ ID NOS: 5-8 (FIGS. 
9-12), and conservative variations, comprise the synthetic 
peptides of the invention. As used herein, the term “synthetic 
peptide” denotes a peptide Which does not comprise an entire 
naturally occurring protein molecule. The peptide is “syn 
thetic” in that it may be produced by human intervention 
using such techniques as chemical synthesis, recombinant 
genetic techniques, or fragmentation of Whole antigen or the 
like. 
Peptides of the invention can be synthesiZed by such com 
monly used methods as t-BOC or FMOC protection of alpha 
amino groups. Both methods involve stepWise syntheses 
Whereby a single amino acid is added at each step starting 
from the C-terminus of the peptide (See, Coligan, et al., 
Current Protocols in Immunology, Wiley Interscience, 1991, 
Unit 9). Peptides of the invention can also be synthesiZed by 
the Well knoWn solid phase peptide synthesis methods 
described in Merri?eld, J. Am. Chem. Soc., 8512149, 1962, 
and SteWart and Young, Solid Phase Peptides Synthesis, 
(Freeman, San Francisco, 1969, pp. 27-62), using a copoly 
(styrene-divinylbenZene) containing 0.1-1.0 mMol amines/ g 
polymer. On completion of chemical synthesis, the peptides 
can be deprotected and cleaved from the polymer by treat 
ment With liquid HF-10% anisole for about 1/4-1 hours at 00 C. 
After evaporation of the reagents, the peptides are extracted 
from the polymer With 1% acetic acid solution Which is then 
lyophiliZed to yield the crude material. This can normally be 
puri?ed by such techniques as gel ?ltration on Sephadex G-15 
using 5% acetic acid as a solvent. LyophiliZation of appropri 
ate fractions of the column Will yield the homogeneous pep 
tide orpeptide derivatives, Which can then be characterized by 
such standard techniques as amino acid analysis, thin layer 
chromatography, high performance liquid chromatography, 
ultraviolet absorption spectroscopy molar, rotation, solubil 
ity, and quantitated by the solid phase Edman degradation. 
The invention also provides polynucleotides Which encode 
the class I and II synthases of the invention and the synthetic 
peptides of SEQ ID NOS. 5-8 (FIGS. 9-12) and those 
sequences having substantial identity to the same. The nucle 
otide sequence of OsCPSlem comprises the sequence found 
in SEQ ID NO. 9. (FIG. 9). The nucleotide sequence of 
OsCPS2em comprises the sequences found in SEQ ID NOS. 
10-12. (FIG. 10). The nucleotide sequence of OsCPS4Syn 
comprises the sequences found in SEQ ID NOS. 13-15. (FIG. 
11). The nucleotide sequence of OsDTS2 comprises the 
sequence found in SEQ ID NO. 16. 
As used herein, “polynucleotide” refers to a polymer of 
deoxyribonucleotides or ribonucleotides, in the form of a 
separate fragment or as a component of a larger construct. As 
used herein, “percentage of sequence identity” means the 
value determined by comparing tWo optimally aligned 
sequences over a comparison WindoW, Wherein the portion of 
the polynucleotide sequence in the comparison WindoW may 
comprise additions or deletions (i.e., gaps) as compared to the 
reference sequence (Which does not comprise additions or 
deletions) for optimal alignment of the tWo sequences. The 
percentage is calculated by determining the number of posi 
tions at Which the identical nucleic acid base or amino acid 
residue occurs in both sequences to yield the number of 
matched positions, dividing the number of matched positions 



































